- Home
- PBYI vs QUIK Comparison
PBYI vs QUIK Comparison
Compare PBYI & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- QUIK
- Stock Information
- Founded
- PBYI 2010
- QUIK 1988
- Country
- PBYI United States
- QUIK United States
- Employees
- PBYI N/A
- QUIK N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- QUIK Semiconductors
- Sector
- PBYI Health Care
- QUIK Technology
- Exchange
- PBYI Nasdaq
- QUIK Nasdaq
- Market Cap
- PBYI 126.5M
- QUIK 118.5M
- IPO Year
- PBYI N/A
- QUIK 1997
- Fundamental
- Price
- PBYI $2.83
- QUIK $8.26
- Analyst Decision
- PBYI Strong Buy
- QUIK Strong Buy
- Analyst Count
- PBYI 1
- QUIK 2
- Target Price
- PBYI $7.00
- QUIK $12.50
- AVG Volume (30 Days)
- PBYI 257.4K
- QUIK 118.9K
- Earning Date
- PBYI 10-31-2024
- QUIK 11-12-2024
- Dividend Yield
- PBYI N/A
- QUIK N/A
- EPS Growth
- PBYI N/A
- QUIK N/A
- EPS
- PBYI 0.18
- QUIK 0.13
- Revenue
- PBYI $219,143,000.00
- QUIK $24,278,000.00
- Revenue This Year
- PBYI N/A
- QUIK $17.17
- Revenue Next Year
- PBYI N/A
- QUIK $31.21
- P/E Ratio
- PBYI $15.55
- QUIK $65.38
- Revenue Growth
- PBYI N/A
- QUIK 66.32
- 52 Week Low
- PBYI $2.13
- QUIK $7.01
- 52 Week High
- PBYI $7.73
- QUIK $20.75
- Technical
- Relative Strength Index (RSI)
- PBYI 59.52
- QUIK 51.44
- Support Level
- PBYI $2.79
- QUIK $7.54
- Resistance Level
- PBYI $2.93
- QUIK $9.15
- Average True Range (ATR)
- PBYI 0.12
- QUIK 0.40
- MACD
- PBYI 0.04
- QUIK 0.08
- Stochastic Oscillator
- PBYI 80.77
- QUIK 47.65
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.